Explore the journey of Georgie Swallow who was diagnosed with Stage 4 Hodgkin Lymphoma after ignoring symptoms Read ahead to ...

Young patients with low-risk, relapsed Hodgkin lymphoma may be able to avoid transplant, data from 3 studies suggest.

Non-transplant salvage therapy for low-risk relapsed/refractory pediatric classical Hodgkin lymphoma (cHL) had high rates of ...

A 19-year-old has shared the pre-cancer symptoms he noticed prior to being diagnosed with with stage four Hodgkin lymphoma.

A new study explores PET-guided risk stratification to tailor salvage therapy in pediatric relapsed/refractory Hodgkin ...

Axicabtagene ciloleucel had durable responses, long-term survival, and consistent outcomes in patients with relapsed or ...

A recent retrospective study has shed new light on the effectiveness of chimeric antigen receptor T cell therapy for patients ...

Non-Hodgkin's lymphoma invades the brain ... Methotrexate-based regimens, even when radiation is deferred, prolong overall survival to over 5 years, but relapses eventually occur in most cases.

Georgie Swallow was just 28-years-old when she received the devastating news that she had stage 4 Hodgkin lymphoma ...

Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in ...

Non-Hodgkin lymphoma is a cancer that affects lymphocytes, a type of white blood cells in the lymphatic system. They are generally classified according to the cancer's growth rate as high grade ...

Tafasitamab increased progression free survival by about 9 months when compared to placebo, according to recent study data.